DrugPatentWatch Database Preview

Drugs in Development Information for Givinostat

« Back to Dashboard

Summary for Givinostat

US Patents	7
International Patents	58
US Patent Applications	14
WIPO Patent Applications	10
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2016-10-01)
Vendors	16

US Patents for Givinostat

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Givinostat		Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester	Italfarmaco SpA (Milano, IT)
Givinostat		Method for treating Philadelphia-negative myeloproliferative syndromes	Italfarmaco SpA (Milan, IT)
Givinostat		Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester	Chemi SPA (Cinisello Balsamo, IT)
Givinostat		Thioxanthone-based autophagy inhibitor therapies to treat cancer	Spectrum Pharmaceuticals, Inc. (Irvine, CA)
Givinostat		Derivatives of N-hydroxybenzamide for treating HIV infections	Italfarmaco S.p.A. (Milan, IT)
Givinostat		Thioxanthone-based autophagy inhibitor therapies to treat cancer	Spectrum Pharmaceuticals, Inc. (Irvine, CA)

International Patents for Givinostat

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Givinostat	European Patent Office	1583737	2023-01-17
Givinostat	Spain	2372280	2023-01-17
Givinostat	Italy	MI20030063	2023-01-17
Givinostat	Japan	2006515028	2023-01-17
Givinostat	Japan	4425906	2023-01-17
Givinostat	World Intellectual Property Organization (WIPO)	2004065355	2023-01-17